-
Anticancer Agents Med Chem · Jun 2008
ReviewInhibition of receptor tyrosine kinases in combination with chemotherapy for the treatment of breast cancer.
- S L Moulder, B S Craft, and G N Hortobagyi.
- Department of Breast Medical Oncology and Phase I Program, The University of Texas M. D. Anderson Cancer Center, 1155 Pressler Street, P.O. Box 301438, Houston, TX 77030, USA. smoulder@mdanderson.org
- Anticancer Agents Med Chem. 2008 Jun 1; 8 (5): 481-7.
AbstractAlthough significant advances have been made in the treatment of breast cancer using chemotherapy, less than half of the patients treated for localized breast cancer benefit from adjuvant chemotherapy and most patients with metastatic cancer eventually develop disease that is chemotherapy resistant. Targeted agents, such as inhibitors of tyrosine kinases, offer the opportunity to reverse chemotherapy resistance and enhance response in patients with localized and advanced breast cancer. Such combined approaches have been established for the treatment of advanced breast cancer and are now demonstrating benefit in the adjuvant arena. This review summarizes the results of several trials involving the use of tyrosine kinase inhibition in combination with chemotherapy for the treatment of breast cancer and discusses future directions for breast cancer biotherapy.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..